BACKGROUND AND OBJECTIVESDentists suffer a high prevalence of musculoskeletal disorders (MSDs) but studies are quite limited. The present study was carried out to investigate the prevalence of MSDs among dentists in the Ha’il Region, Saudi Arabia.DESIGN AND SETTINGSA cross-sectional, questionnaire study was conducted among 80 licensed dentists affiliated with the Ministry of Health (MoH), Ha’il Region, Saudi Arabia from January 2014-January 2015.PATIENTS AND METHODSA self-administered questionnaire, based on the Nordic Musculoskeletal Questionnaire (NMQ) was sent to participants after translation to Arabic. The questionnaire was delivered by mail with a prepaid return envelope.RESULTSSixty-eight questionnaires (85%) were returned. The prevalence of MSDs among respondents was 77.9% (n=53) with the most commonly affected areas the lower back (73.5%) (39/53) followed by the neck (66%) (35/53) and the shoulders (43.3%) (23/53). Twenty-four (45.2%) of 53 respondents had experienced MSDs in the neck and lower back at the same time throughout the past twelve months. Nearly 85% (45/53) of respondents were found to have MSDs affecting two or more sites.CONCLUSIONPrevalence of MSDs was high among dentists in the Ha’il region. Lower back, neck and shoulders were the most commonly affected body sites.
Background Butorphanol tartrate, a mixed synthetic agonistantagonist opioid analgesic has been used for management of postoperative pain in minor and major surgical procedures.14,20 Tramadol hydrochloride is a centrally acting opioid which is effectively used in postoperative pain in various minor and major surgeries. Materials and methods Twenty subjects selected randomly received butorphanol tartrate 1 mg intramuscular and 20 subjects received tramadol hydrochloride 50 mg intramuscular after the removal of mandibular third molars. Time of injection, amount of anesthetic injected, duration of surgery, adverse effects were recorded.21 Results The mean amount of LA administered in butorphanol group was 2.6450 ml and in tramadol group was 2.640 ml respectively, the mean duration for surgery was 56.75 and 53.5 minutes for butorphanol and tramadol groups respectively which was statistically not significant. Pain assessment was done with VAS which showed mean of 19.2 and 15.5 mm (p = 0.001) which was significant for butorphanol and tramadol respectively after 12 hours. The mean time for rescue medication requirement was 5.9 hours (for tramadol) and 8.4 hours (for butorphanol). Effective analgesic activity was seen by butorphanol 1 mg intramuscular then tramadol 50 mg. Conclusion Butorphanol 1 mg was more effective than tramadol 50 mg in respect to postoperative analgesia. How to cite this article Hassan SS, Ahmed A, Rai M, Kalappa TM. Analgesic Efficacy of Tramadol and Butorphanol in Mandibular Third Molar Surgery: A Comparative Study. J Contemp Dent Pract 2012;13(3):364-370.
Patient had mouth opening of 29 mm and also had a satisfactory esthetic appearence.
Objective An early identification of patients who are at an obvious increased risk of osteoporosis and subsequent high risk of pathological bone fractures is important to prevent morbidity and its subsequent impact on the quality of life of the affected patients. Dental professionals have a chance of identifying such cases in their very initial stages through routinely prescribed dental radiographs. The aim of this study was to assess the influence of gender and age on different parameters of alveolar bone loss using orthopantomograph (OPG) as an aid to identify patients with low bone mineral density (BMD). Materials and Methods This study included eighty subjects in whom after taking OPGs, mandibular cortical index (MCI), mandibular cortical width (MCW), and panoramic mandibular index were assessed, while the results obtained were subjected to statistical analysis. One-way analysis of variance followed by Tukey's test was used to compare the means, while p-value less than 0.05 was considered statistically significant. Results The findings of this study revealed a significant association between MCI and age for females, with C2 and C3 categories being more common with advancing age. Also, a significant difference could be seen in relation to gender (p-value = 0.0315) for MCW with a concomitant decrease in the values of MCW in females over 60 years of age. Conclusion Panoramic radiographic measurements could provide valuable information and help in screening patients with low BMD.
Background - Odontogenic Keratocyst (OKC) is a developmental cyst of odontogenic origin behaving aggressively in term of high recurrence rate. Aggressive behavior and tendency to recur are related to greater proliferative activity of the epithelial lining. There have been many arguments made and still controversial regarding the treatment option for OKCs. Aim- The aim of the study is to investigate the Prevalence and incidence of OKC Riyadh city and the Assessment of recurrence rate of different management scheme for treatment of OKC. Objective- The objective of this study is to study the efficacy of enucleation with peripheral osteotomy versus resection method in management of OKC. Material and Method-Data has been obtained through a retrospective review of patients admitted at five main oral and maxillo-facial surgery departments in Riyadh City with a diagnosis of OKC. A retrospective review of OKC patients was conducted between July 2010 and December 2022. After excluding patient files with incomplete, unclear data. The data of the patients with a diagnosis of OKC, complete record patients were included in the study. The following data were recorded for each patient: Gender, age, medical history, date of diagnosis, radiology type, location, radiology description, associate complications (local/systematic) biopsy date, biopsy type, histopathology, surgery performed, date primary procedure, post-operative complications (numbness/infection/limited mouth opening/lymphadenopathy) and whether it resolved or not, recurrence, date of recurrence, number of recurrence, time between first surgery and recurrence, secondary procedure for the recurrence, date of secondary procedure, type of the second procedure, complications after the second procedure, date of diagnosis of second recurrence, date of third procedure, type of the third procedure, complications of the third procedure, date of forth procedures, type of the forth procedure, complications after the forth procedure, date of follow- up. Results - The total of 30 patients with clear medical records and at least one follow-up record, with the age ranged from 5 to 53 years, the mean age for patients without recurrence was 30.8 ± 11.7 years, while for those with recurrence, it was 25.3 ± 14.3. The p-value of 0.072 suggests that there is no statistically significant difference between the age of patients who had a recurrence and those who did not. Gender-wise, there were 11 (36.7%) females, 3 of them experienced recurrence. and 19 (63.3%) males, and 9 of them experienced recurrence (table 1). The majority of the patients underwent radiology using CT at the rate of 56.7%, followed by CBCT at the rate of 23.3%. The majority of the patients had a mandible location at the rate of 93.3%, with 70% of them diagnosed with a Unicystic radiological description and the rest were Multicystic. Conclusion - Enucleation was the most common first procedure for treating OKCs of the jaws, and most patients did not experience post-operative complications, but about 40% of the cases has been recurred whatever the procedure was except for the decompression procedure there were no recurrence. Patients who required a secondary procedure were most likely to undergo enucleation. Overall, 60% of patients did not have a recurrence, 33.3% had one recurrence, and 6.7% had two recurrences.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.